Stereotactic radiosurgery of cerebral arteriovenous malformations: Appearance of perinidal T2 hyperintensity signal as a predictor of favorable treatment response

Fardad Mobin, Antonio A F De Salles, Osama Abdelaziz, Cynthia Cabatan-Awang, Timothy Solberg, Michael Selch

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The purpose of this study was to analyze the significance of perinidal T2 hyperintensity appearance after radiosurgery of arteriovenous malformations (AVMs), as a predictor of treatment response. Our initial experience with linear accelerator (LINAC) radiosurgery at University of California, Los Angeles, between 1990 and 1997 involved treatment of 129 patients affected by cerebral AVMs. Based upon availability of neuroimaging follow-up, 48 patients with 50 AVMs were selected for review. Forty (80%) of the AVMs underwent complete obliteration or significant reduction on follow-up MRI, on average 20 months after radiosurgery. Thirteen (72%) of 18 obliterated AVMs were associated with perinidal T2 hyperintensity signal, on average 18 months (6-49) after radiosurgery. Ten (20%) of 50 AVMs (average volume 23.1 cm3, ranging 7.5-46.5) were unchanged. Furthermore, only 3 AVMs in this group showed reversible T2 signal changes. In patients with complete nidal obliteration, appearance on T2 hyperintensity signal achieves 72% sensitivity in predicting successful treatment response. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish (US)
Pages (from-to)50-59
Number of pages10
JournalStereotactic and Functional Neurosurgery
Volume73
Issue number1-4
DOIs
StatePublished - May 2000

Keywords

  • Arteriovenous malformations
  • Magnetic resonance imaging
  • Stereotactic radiosurgery
  • Stereotactic surgery
  • Treatment response

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Stereotactic radiosurgery of cerebral arteriovenous malformations: Appearance of perinidal T2 hyperintensity signal as a predictor of favorable treatment response'. Together they form a unique fingerprint.

Cite this